 |
 |
| Alcon originally entered the market for femtosecond laser-assisted cataract surgery (FLACS) nearly 15 years ago with the $744M acquisition of LenSx. Now it is looking to upgrade its offering with robotic systems from Lensar that promise to make the approach more cost-effective. Image: Boulder Medical Center. |
| © 2025 SPIE Europe |
|
